Parkman Healthcare Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,840
| Closed | -$6.26M | – | 102 |
|
|
2023
Q1 | $6.26M | Buy |
25,840
+18,499
| +252% | +$4.48M | 1.36% | 30 |
|
|
2022
Q4 | $2.13M | Sell |
7,341
-14,249
| -66% | -$4.14M | 0.57% | 56 |
|
|
2022
Q3 | $1.4M | Buy |
21,590
+254
| +1% | +$16.5K | 0.4% | 66 |
|
|
2022
Q2 | $1.53M | Buy |
21,336
+1,106
| +5% | +$79.2K | 0.56% | 49 |
|
|
2022
Q1 | $1.99M | Sell |
20,230
-8,440
| -29% | -$828K | 0.58% | 47 |
|
|
2021
Q4 | $2.43M | Sell |
28,670
-2,723
| -9% | -$231K | 0.54% | 49 |
|
|
2021
Q3 | $2.51M | Sell |
31,393
-5,000
| -14% | -$399K | 0.63% | 49 |
|
|
2021
Q2 | $3.55M | Sell |
36,393
-3,328
| -8% | -$324K | 0.78% | 41 |
|
|
2021
Q1 | $4.65M | Buy |
39,721
+26,745
| +206% | +$3.13M | 1.08% | 30 |
|
|
2020
Q4 | $1.44M | Sell |
12,976
-5,235
| -29% | -$582K | 0.37% | 67 |
|
|
2020
Q3 | $2.16M | Sell |
18,211
-31,789
| -64% | -$3.77M | 0.57% | 56 |
|
|
2020
Q2 | $5.66M | Buy |
50,000
+20,000
| +67% | +$2.27M | 1.6% | 26 |
|
|
2020
Q1 | $2M | Buy |
+30,000
| New | +$2M | 0.93% | 36 |
|